Correction to our Letter to the Editor about "CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer"
- PMID: 30575475
- DOI: 10.1056/NEJMc1814750
Correction to our Letter to the Editor about "CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer"
Erratum for
-
CDX2 as a Prognostic Biomarker in Colon Cancer.N Engl J Med. 2016 Jun 2;374(22):2182. doi: 10.1056/NEJMc1602584. N Engl J Med. 2016. PMID: 27248628 No abstract available.
Comment on
-
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.N Engl J Med. 2016 Jan 21;374(3):211-22. doi: 10.1056/NEJMoa1506597. N Engl J Med. 2016. PMID: 26789870 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources